|
Match
|
Document |
Document Title |
|
|
6852708 |
Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls
For the prevention of the narrowing of the tubular walls of an animal after the tubular walls have been traumatized, the administration of a therapeutically effective non-toxic amount of a form of...
|
|
|
6825234 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides compositions and methods suitable for ameliorating female sexual dysfunction, and in particular, female sexual arousal disorder. In one embodiment, the invention provides a...
|
|
|
6486207 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides a composition suitable for topical application comprising: an effective amount of a prostaglandin, a polymer thickener, a lipophilic component, and a buffer system. In...
|
|
|
6218373 |
Formulations containing hyaluronic acid
A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a...
|
|
|
6207185 |
Method for inducing a systemic immune response to an HIV antigen
A method is provided for inducing a systemic immune response to an antigen selected from inactivated HIV I and HIV II antigens in a mammal. The method comprises orally administering lyophilized...
|
|
|
6140312 |
Formulations containing hyaluronic acid
The invention relates to a method of rapidly transporting a drug to the epidermis and accumulating and maintaining the drug therein for a prolonged period of time comprising administration of a...
|
|
|
6117449 |
Method for inducing a systemic immune response to a hepatitis antigen
A method is provided for inducing a systemic immune response to an antigen selected from hepatitis B and hepatitis C antigens in a mammal. The method comprises orally administering lyophilized...
|
|
|
6030639 |
Treatment using prostoglandin and particulate formulations
Provided herein is a method of administering a free arachidonic acid metabolite to an animal, the method involving administration of the free metabolite and an endocytosable particle. This method...
|
|
|
6015576 |
Method for inducing a systemic immune response to an antigen
A method is provided for inducing a systemic immune response to an antigen in a mammal. The method comprises orally administering lyophilized multilamellar liposomes containing the antigen. The...
|
|
|
5990096 |
Formulations containing hyaluronic acid
The invention relates to a method of controlling the unloading of a drug from the skin or exposed tissue of a human into the lymphatic system comprising transporting an effective dosage amount of...
|
|
|
5977088 |
Formulations containing hyaluronic acid
Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount...
|
|
|
5962433 |
Topical composition containing hyaluronic acid and NSAIDS
A pharmaceutical composition is provided comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology and/or trauma of skin...
|
|
|
5925375 |
Therapeutic use of multilamellar liposomal prostaglandin formulations
This invention provides a multilamellar liposome containing an arachidonic acid metabolite, two or more lipid-containing bilayers and two or more aqueous compartments containing a...
|
|
|
5910489 |
Topical composition containing hyaluronic acid and NSAIDS
A pharmaceutical composition comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology and/or trauma of skin and/or exposed...
|
|
|
5882678 |
Interdigitation-fusion liposomes containing arachidonic acid metabolites
This invention provides an interdigitation-fusion liposome comprising an arachidonic acid metabolite, a lipid bilayer comprising a lipid and an aqueous compartment comprising a release-inhibiting...
|
|
|
5840328 |
Treatment using arachidonic acid metabolite and particulate formulations
A composition comprises a free arachidonic acid metabolite and endocystosable particles such as phagocytosable or opsonizable particles, or particles binding to phagocytic receptors to serum...
|
|
|
5824658 |
Topical composition containing hyaluronic acid and NSAIDS
A method of treating pain topically, said method comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage amount...
|
|
|
5814301 |
Use of prostacyclin derivatives to prevent or to treat disorders of the microcirculatory system when x-ray, NMR or ultrasonic contrast media are administered
Use of a prostacyclin derivative of general formula I ##STR1## in which R 1 , X, Y, Z, A, W, D, E, R 2 and R 3 may have different meanings, for the production of a pharmaceutical agent to prevent...
|
|
|
5811118 |
Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
This invention provides a method of administering an arachidonic acid metabolite, such as prostaglandin E1, to an animal. The metabolite is given to the animal, typically a human, in association...
|
|
|
5767106 |
Treatment of disease and conditions associated with macrophage infiltration
A method of treating a human having a disease or condition characterized by macrophage, neutrophile or other white blood cell infiltration into the area damaged by the disease or condition, the...
|
|
|
5718917 |
PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
A method for the treatment of erectile dysfunction comprises instilling intra meatally an aqueous solution containing prostaglandin-containing liposomes and a detergent for lysing the liposomes. A...
|
|
|
5445812 |
Angiographic adjuvant
An angiographic adjuvant comprising a fat emulsion containing a compound having prostaglandin E1 activities, and an angiographic method using the adjuvant.
|
|
|
5171217 |
Method for delivery of smooth muscle cell inhibitors
A method and composition for delivering a drug to an affected intramural site for sustained release in conjunction with or following balloon catheter procedures, such as angioplasty. The drug,...
|
|
|
5166143 |
Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering an ACE inhibitor such as fosinopril or ceranapril, prior to, during and/or after...
|